Janus Henderson Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Sell |
33,389
-848
| -2% | -$30.5K | ﹤0.01% | 1528 |
|
|
2025
Q1 | $1.07M | Hold |
34,237
| – | – | ﹤0.01% | 1583 |
|
|
2024
Q4 | $873K | Sell |
34,237
-1,729,008
| -98% | -$44.1M | ﹤0.01% | 1761 |
|
|
2024
Q3 | $49.9M | Sell |
1,763,245
-4,172
| -0.2% | -$118K | 0.03% | 390 |
|
|
2024
Q2 | $46.6M | Sell |
1,767,417
-85,243
| -5% | -$2.25M | 0.03% | 394 |
|
|
2024
Q1 | $56.3M | Sell |
1,852,660
-47,954
| -3% | -$1.46M | 0.03% | 369 |
|
|
2023
Q4 | $53.4M | Sell |
1,900,614
-335,782
| -15% | -$9.43M | 0.03% | 361 |
|
|
2023
Q3 | $60.7M | Sell |
2,236,396
-37,704
| -2% | -$1.02M | 0.04% | 333 |
|
|
2023
Q2 | $69.9M | Sell |
2,274,100
-289,895
| -11% | -$8.91M | 0.04% | 322 |
|
|
2023
Q1 | $92.4M | Sell |
2,563,995
-36,506
| -1% | -$1.32M | 0.06% | 264 |
|
|
2022
Q4 | $103M | Sell |
2,600,501
-2,927,661
| -53% | -$116M | 0.07% | 237 |
|
|
2022
Q3 | $222M | Buy |
5,528,162
+2,421,561
| +78% | +$97.3M | 0.08% | 221 |
|
|
2022
Q2 | $131M | Buy |
3,106,601
+323,775
| +12% | +$13.6M | 0.09% | 217 |
|
|
2022
Q1 | $108M | Buy |
2,782,826
+212,647
| +8% | +$8.28M | 0.05% | 298 |
|
|
2021
Q4 | $102M | Buy |
2,570,179
+207,885
| +9% | +$8.28M | 0.04% | 352 |
|
|
2021
Q3 | $85.4M | Sell |
2,362,294
-1,383,120
| -37% | -$50M | 0.04% | 391 |
|
|
2021
Q2 | $154M | Buy |
3,745,414
+2,505,360
| +202% | +$103M | 0.07% | 290 |
|
|
2021
Q1 | $54.1M | Sell |
1,240,054
-3,661,646
| -75% | -$160M | 0.02% | 529 |
|
|
2020
Q4 | $245M | Buy |
4,901,700
+177,056
| +4% | +$8.86M | 0.11% | 192 |
|
|
2020
Q3 | $199M | Buy |
4,724,644
+217,506
| +5% | +$9.15M | 0.1% | 202 |
|
|
2020
Q2 | $219M | Buy |
+4,507,138
| New | +$219M | 0.12% | 180 |
|